The genesis of MEGA BIOPHARMA

1982

Start of research works by the Doctors Camprasse on mother-of-pearl.

1983

Invention of Bionacre® biomaterial
Proof of its safety and biocompatibility in respect of human subjects.

1985

Design of dental implant prototypes based on Bionacre®
Filing of the first patents – First clinical cases in humans

1988

First publications and conferences: emergence of international interest in mother-of-pearl and Bionacre® biomaterial

1989

Joel Drai set up MEGA INDUSTRIE, a group specialising in the distribution of dental and pharmaceutical products aimed at healthcare professionals

1991

Joel Drai set up MEGA DENTAL, specialising in the distribution of dental and orthodontic supplies, quickly becoming a market leader

2007

With a view to promoting innovation, MEGA INDUSTRIE developed MY PEARL , a manufacturer of a revolutionary dental alignment system, and FEEDJI, a platform to manage exchanges between dental surgeons and mutual insurance companies

Key dates in the MEGA BIOPHARMA story

2009

Decisive meeting of Joel Drai and the Doctors Camprasse, crystallising the setup of MEGA BIOPHARMA.

2010

Building of our R&D laboratory and production site, in Teloché (Le Mans). Structuring of the company, with the appointment of Dominique Gourmelen as CEO.

2015 - 2018

Studies and publications with Professor Chappard (GEROM CGU Angers) on sheep. Validation of the osseointegration and erodibility properties of mother-of-pearl.

Collaboration with BPI France to support MEGA BIOPHARMA in the development of its fundamental research and in the production of medical devices. Filing and registration of multiple patents (in France and beyond).

The clean room in Teloché (R&D and production)

2019

First capital raising through private investors

Development of the company via new appointments (Regulatory affairs, R&D, Product development, Marketing, Communication, Finance) and new collaborations (Doctor Marc Slama).

2020

Opening of the Paris office, development of commercial activity.

Building of our new R&D laboratory and production site, in Crosne.

Publication by the Doctors Camprasse, along with Professor Chappard, on the osseointegration and the erodibility of mother-of-pearl screws.

Mega Biopharma articles

Critical clinical case – Dallas - Case Study